BRIEF-BeOne Medicines said Facilities Agreement provides U.S. Dollar-denominated, B1 revolving loan facility of $140 million

Reuters11-19
BRIEF-BeOne Medicines said Facilities Agreement provides U.S. Dollar-denominated, B1 revolving loan facility of $140 million

Nov 19 (Reuters) - BeOne Medicines AG 688235.SS:

  • BEONE MEDICINES LTD - FACILITIES AGREEMENT PROVIDES U.S. DOLLAR-DENOMINATED, B1 REVOLVING LOAN FACILITY OF $140 MILLION

  • BEONE MEDICINES LTD - FACILITIES AGREEMENT PROVIDES U.S. DOLLAR-DENOMINATED, B2 TERM LOAN FACILITY OF $560 MILLION

  • BEONE MEDICINES LTD - FACILITIES AGREEMENT PROVIDES RENMINBI-DENOMINATED, A TERM LOAN FACILITY OF ABOUT $300 MILLION

  • BEONE MEDICINES LTD - ACCORDION FEATURE ALLOWS B LOAN FACILITIES INCREASE TO $700 MILLION - SEC FILING

Further company coverage: 688235.SS

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment